Close Menu

NEW YORK –  Agilent Technologies and Danish digital pathology software firm Visiopharm said on Monday they will comarket Visiopharm's portfolio of AI-driven pathology solutions.

The deal addresses the unmet needs of pathology labs, the partners said, adding the goal is to provide technologies, products, and services that will improve the standardization of pathology labs and accelerate accurate diagnoses.

Financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.